MedPath

Observational Study of Patients With Subarachnoid Hemorrhage

Conditions
Subarachnoid Hemorrhage
Registration Number
NCT02890004
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

This prospective, observational study aim to identify :

* Prognostic factor of patients with subarachnoid haemorrhage in neuro intensive care unit

* The impact of standard therapeutic used (surgery, embolization ; medical treatment of vasospasm ; treatment of complications like hyponatremia, stress myocardiopathy, ...)

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Subarachnoid hemorrhage
Read More
Exclusion Criteria
  • None
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Survivalat 12 months
Secondary Outcome Measures
NameTimeMethod
Neurological outcome with the Glasgow Coma Scale (GCS) scoreat 12 months
Neuropsychological outcome with the Montreal Cognitive Assessment (MoCA) scoreat 12 months
Brain lesions with MRIat 12 months
delay of apparition of hyponatremiaon alternte days after Day 0

Natremia in standard blood sample, Natremia is routinelly evaluated on alternte days, and more if required.

Trial Locations

Locations (1)

Service de réanimation polyvalente neurologique Hôpital Neurologique HCL

🇫🇷

Bron, France

© Copyright 2025. All Rights Reserved by MedPath